Schizophrenia research priorities from the viewpoint of patients/relatives

Abstract

5. Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Young LJ (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery 2012; 11(2): 141–168. http://doi.org/10.1038/nrd3628 6. Söderlund J, Wicks S, Jörgensen L, Dalman C. Comparing cohort incidence of schizophrenia with that of bipolar disorder and affective psychosis in individuals born in Stockholm County 2015; 1955–1967. Psychological Medicine, 45(16), 3433–9. http://doi.org/10.1017/S0033291715001336 7. Turner DT, van der Gaag M, Karyotaki E, Cuijpers P. Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. The American Journal of Psychiatry 2014; 171(5): 523–538. Retrieved from http://europepmc.org/abstract/ MED/24525715 8. van den Heuvel MP, Sporns O. Rich-club organization of the human connectome. The Journal of Neuroscience 2011; 31(44): 15775–15786. http://doi.org/10.1523/JNEUROSCI.3539–11.2011 9. Wittchen H-U, Knappe S, Andersson G, Araya R, Banos Rivera RM, Barkham M, Schumann G. The need for a behavioural science focus in research on mental health and mental disorders. International Journal of Methods in Psychiatric Research 2014; 23(S1): 28–40. http://doi.org/10.1002/mpr.1409 10.Wooding S, Pollitt A, Castle-Clarke S, Cochrane G, Diepeveen S, Guthrie S, Grant J. Mental Health Retrosight: Understanding the returns from research (lessons from schizophrenia). Santa Monica, CA 2013. 11.Wykes T, Haro JM, Belli SR, Obradors-Tarragó C, Arango C, AyusoMateos JL, Wittchen H-U. Mental health research priorities for Europe. The Lancet. Psychiatry 2015; 2(11): 1036–1042. http://doi.org/10.1016/S2215–0366(15)00332–6 12.Wykes T, Steel C, Everitt B, Tarrier N. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor. Schizophrenia Bulletin 2008; 34(3): 523–537. http://doi.org/10.1093/schbul/sbm114 13.Dayalu P, Chou KL. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opinion on Pharmacotherapy 2008; 9(9): 1451–1462. 14. Lazarus JH. Lithium and thyroid. Best Practice & Research: Clinical Endocrinology & Metabolism 2009; 23(6): 723–733. http://doi.org/10.1016/j.beem.2009.06.002